Literature DB >> 32632555

Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept.

Zine-Eddine Khene1,2, Romain Mathieu3, Benoit Peyronnet3, Romain Kokorian4, Anis Gasmi3, Fares Khene3, Nathalie Rioux-Leclercq5, Solène-Florence Kammerer-Jacquet5, Shahrokh Shariat6, Brigitte Laguerre4, Karim Bensalah3.   

Abstract

Entities:  

Keywords:  Immunotherapy; Kidney cancer; Machine learning; Prediction model; Radiomics; Renal cell carcinoma

Mesh：

Substances：

Year:  2020        PMID： 32632555     DOI： 10.1007/s00345-020-03334-5

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  6 in total

1.  Predictive Role of Computed Tomography Texture Analysis in Patients with Metastatic Urothelial Cancer Treated with Programmed Death-1 and Programmed Death-ligand 1 Inhibitors.

Authors:  Francesco Alessandrino; Rahul Gujrathi; Amin H Nassar; Arwa Alzaghal; Arvind Ravi; Bradley McGregor; Guru Sonpavde; Atul B Shinagare
Journal:  Eur Urol Oncol       Date:  2019-03-09

2.  Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness.

Authors:  Ashutosh K Tewari; Bachir Taouli; Stefanie J Hectors; Mathew Cherny; Kamlesh K Yadav; Alp Tuna Beksaç; Hari Thulasidass; Sara Lewis; Elai Davicioni; Pei Wang
Journal:  J Urol       Date:  2019-08-08       Impact factor: 7.450

Review 3.  An Update on Predictive Biomarkers in Metastatic Renal Cell Carcinoma.

Authors:  Shaan Dudani; Marie-France Savard; Daniel Y C Heng
Journal:  Eur Urol Focus       Date:  2019-04-20

4.  Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.

Authors:  Robert J Motzer; Bernard Escudier; David F McDermott; Saby George; Hans J Hammers; Sandhya Srinivas; Scott S Tykodi; Jeffrey A Sosman; Giuseppe Procopio; Elizabeth R Plimack; Daniel Castellano; Toni K Choueiri; Howard Gurney; Frede Donskov; Petri Bono; John Wagstaff; Thomas C Gauler; Takeshi Ueda; Yoshihiko Tomita; Fabio A Schutz; Christian Kollmannsberger; James Larkin; Alain Ravaud; Jason S Simon; Li-An Xu; Ian M Waxman; Padmanee Sharma
Journal:  N Engl J Med       Date:  2015-09-25       Impact factor: 91.245

Review 5.  Artificial intelligence for precision oncology: beyond patient stratification.

Authors:  Francisco Azuaje
Journal:  NPJ Precis Oncol       Date:  2019-02-25

6.  Duplication of a promiscuous transcription factor drives the emergence of a new regulatory network.

Authors:  Ksenia Pougach; Arnout Voet; Fyodor A Kondrashov; Karin Voordeckers; Joaquin F Christiaens; Bianka Baying; Vladimir Benes; Ryo Sakai; Jan Aerts; Bo Zhu; Patrick Van Dijck; Kevin J Verstrepen
Journal:  Nat Commun       Date:  2014-09-10       Impact factor: 14.919
  6 in total
  4 in total

Review 1.  Imaging approaches and radiomics: toward a new era of ultraprecision radioimmunotherapy?

Authors:  Roger Sun; Théophraste Henry; Adrien Laville; Alexandre Carré; Anthony Hamaoui; Sophie Bockel; Ines Chaffai; Antonin Levy; Cyrus Chargari; Charlotte Robert; Eric Deutsch
Journal:  J Immunother Cancer       Date:  2022-07       Impact factor: 12.469

2.  Inhibitory Effect of Ursolic Acid on Proliferation and Migration of Renal Carcinoma Cells and Its Mechanism.

Authors:  Xiao Lyu; Xuhui Zhang; Libin Sun; Jingqi Wang; Dongwen Wang
Journal:  Comput Intell Neurosci       Date:  2022-05-04

Review 3.  Artificial Intelligence Applications in Urology: Reporting Standards to Achieve Fluency for Urologists.

Authors:  Andrew B Chen; Taseen Haque; Sidney Roberts; Sirisha Rambhatla; Giovanni Cacciamani; Prokar Dasgupta; Andrew J Hung
Journal:  Urol Clin North Am       Date:  2021-10-23       Impact factor: 2.766

Review 4.  Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee.

Authors:  Brian Gastman; Piyush K Agarwal; Adam Berger; Genevieve Boland; Stephen Broderick; Lisa H Butterfield; David Byrd; Peter E Fecci; Robert L Ferris; Yuman Fong; Stephanie L Goff; Matthew M Grabowski; Fumito Ito; Michael Lim; Michael T Lotze; Haider Mahdi; Mokenge Malafa; Carol D Morris; Pranav Murthy; Rogerio I Neves; Adekunle Odunsi; Sara I Pai; Sangeetha Prabhakaran; Steven A Rosenberg; Ragheed Saoud; Jyothi Sethuraman; Joseph Skitzki; Craig L Slingluff; Vernon K Sondak; John B Sunwoo; Simon Turcotte; Cecilia Cs Yeung; Howard L Kaufman
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 12.469
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.